第二条 本制度适用于公司董事（含独立董事、职工代表董事）、高级管理 人员因任期届满、辞职、被解除职务或其他原因离职的情形。 第一章 总则 第一条 为规范益丰大药房连锁股份有限公司（以下简称"公司"）董事、高 级管理人员离职管理，保障公司治理稳定性及股东合法权益，根据《中华人民 共和国公司法》（以下简称《公司法》）、《上市公司章程指引》《上市公司 董事和高级管理人员所持本公司股份及其变动管理规则》等法律法规、规范性 文件和《公司章程》的规定，制定本制度。 益丰大药房连锁股份有限公司 董事、高级管理人员离职管理制度 第三条 公司董事、高级管理人员离职管理应遵循以下原则： （一）合法合规原则：严格遵守国家法律法规、监管规定及《公司章程》 的要求； 第二章 离职情形与程序 第四条 公司董事、高级管理人员离职包含任期届满未连任、主动辞职、被解除 职务以及其他导致董事实际离职等情形。 第五条 公司董事、高级管理人员可以在任期届满以前辞任。公司董事、高 级管理人员辞任应当提交书面辞职报告。高级管理人员辞任的，自董事会收到 辞职报告时生效。 第六条 公司应在收到辞职报告后2个交易日内披露董事、高级管理人员离 任公告，应当在公 ...

Core Viewpoint - The company plans to use its own funds to pay part of the expenses for the "Digital Platform Upgrade Project" and subsequently replace these with raised funds, amounting to no more than 7.05 million yuan [1][4]. Fundraising Basic Situation - The company issued 17,974,320 convertible bonds at a face value of 100 yuan each, raising a total of 1.797 billion yuan, with net proceeds after deducting issuance costs amounting to 1.327 billion yuan [1][2]. Investment Project Basic Situation - As of June 30, 2025, the total investment for the projects is 2.534 billion yuan, with 1.797 billion yuan planned to be funded by the raised funds, and 443.06 million yuan already utilized [2][3]. Reasons for Using Own Funds - The company needs to use its own funds for salary and social insurance payments during the project implementation, as these payments must be processed through the company's basic deposit account [3][4]. Impact on the Company - The use of self-funds followed by replacement with raised funds is expected to enhance the efficiency of fund utilization and overall operational management, ensuring the smooth progress of the investment project [4][5]. Review Procedures and Opinions - The board and supervisory committee approved the proposal to use self-funds for the project, confirming that this does not harm the interests of the company or its shareholders and complies with relevant regulations [5][6].

Core Viewpoint - The company has announced an extension of the completion date for its fundraising investment project, the "Digital Platform Upgrade Project," from July 31, 2025, to December 31, 2025, without changing the project implementation subject, method, total investment, or use of funds [1][4]. Fundraising Basic Information - The company issued 17,974,320 convertible bonds at a face value of RMB 100 each, raising a total of RMB 1.797 billion, with net proceeds after deducting issuance costs amounting to RMB 1.793 billion [1][2]. Fundraising Usage Status - As of June 30, 2025, the total investment for the "Digital Platform Upgrade Project" is RMB 80.642 million, with RMB 73.621 million already invested, representing a progress rate of 91.29% [2][3]. Reasons for Project Delay - The delay in the "Digital Project" is attributed to the complexity of integrating multiple systems (product, logistics, finance, and human resources), which has led to challenges in platform integration and promotion [3][4]. Impact of Project Delay - The project delay is a cautious decision based on actual implementation conditions and will not adversely affect the company's normal operations or harm the interests of shareholders, particularly minority shareholders [4][5]. Review Procedures and Opinions - The board of directors and the supervisory board approved the extension of the project completion date during meetings held on July 30, 2025, confirming that the decision complies with relevant laws and regulations [4][5].

益丰大药房连锁股份有限公司 投资者关系管理制度 （经第五届董事会第十九次会议审议通过） 第一章 总则 第一条 为促进和完善益丰大药房连锁股份有限公司（以下简称"公司"） 治理结构，规范公司投资者关系管理工作，切实保护投资者特别是社会公众投资 者的合法权益，根据《中华人民共和国公司法》、《中华人民共和国证券法》《上 海证券交易所股票上市规则》《上市公司投资者关系管理工作指引》及其他相关 法律、法规和规定，并结合公司的实际情况，特制定本制度。 第二条 投资者关系管理是指公司通过各种方式的投资者关系活动，加强与 投资者和潜在投资者（以下统称"投资者"）之间的沟通和交流，增进投资者对 公司的了解，以实现公司、股东及其他相关利益者合法权益最大化和保护投资者 合法权益的一项战略性管理行为。 第二章 投资者关系管理的基本原则、目的及工作对象 第三条 投资者关系管理的基本原则 （一）合规性原则。公司投资者关系管理应当在依法履行信息披露义务的基 础上开展，符合法律、法规、规章及规范性文件、行业规范和自律规则、公司内 部规章制度，以及行业普遍遵守的道德规范和行为准则； （二）平等性原则。公司开展投资者关系管理活动，应当平等对待所 ...

益丰大药房连锁股份有限公司 对外投资管理制度 第一章 总则 第一条 为了加强益丰大药房连锁股份有限公司（以下简称"公司"）对外投 资活动的内部控制，规范对外投资行为，防范对外投资风险，保障对外投资安全， 提高对外投资效益，根据《中华人民共和国公司法》 （以下简称"《公司法》"）和 《益丰大药房连锁股份有限公司公司章程》（以下简称"《公司章程》"）的相关规 定，制定本制度。 第二条 本制度所称对外投资是指公司为实现扩大生产经营规模的战略，达 到获取长期收益为目的，将现金、实物、无形资产等可供支配的资源投向其他组 织或个人的行为。通过股权投资（具体包括新设、参股、并购、重组、股权置换、 股份增持或减持、参与及设立产业投资基金等）、委托管理（含委托理财、委托贷 款等）、证券投资（含股票、债券、基金、银行理财产品等）以及国家法律法规允 许的其他形式，向境内外的其他单位进行的各项投资活动。 第三条 本制度旨在建立有效的投资机制，对公司和子公司的对外投资活动 进行决策管理，以保障对外投资的科学决策、规范化运作和投资成效。 第四条 对外投资的原则 （一）遵守国家法律、行政法规、规章制度，符合《公司章程》规定； （二）符合公 ...

Core Points - Yifeng Pharmacy Chain Co., Ltd. is established as a joint-stock company in accordance with the Company Law and Securities Law of the People's Republic of China [1][2] - The company was approved for public offering of 40 million shares and listed on the Shanghai Stock Exchange on February 17, 2015 [1][2] - The registered capital of the company is RMB 1,212,432,297 [2][4] Chapter 1: General Provisions - The purpose of the articles is to protect the legal rights of the company, shareholders, employees, and creditors [1] - The company is registered in Changde City, Hunan Province, with a business license number of 430700000011314 [1][2] - The chairman serves as the legal representative of the company, and the company must appoint a new legal representative within 30 days if the current one resigns [2][3] Chapter 2: Business Objectives and Scope - The company's business objective is to provide valuable goods and services for human health [4] - The business scope includes food sales, drug retail, medical services, and various other health-related services [4][5] Chapter 3: Shares - The company's shares are issued in the form of stocks, with a total of 1,212,432,297 shares, all of which are ordinary shares with a par value of RMB 1 [7][18] - The issuance of shares follows principles of openness, fairness, and justice, ensuring equal rights for all shareholders of the same class [7][8] - The company can increase capital through various methods, including issuing shares to unspecified objects or existing shareholders [20][21] Chapter 4: Shareholders and Shareholder Meetings - Shareholders have rights to dividends, attend meetings, supervise the company, and access company documents [12][13] - The company must hold an annual general meeting within six months after the end of the previous fiscal year [46] - Shareholders holding more than 10% of shares can request a temporary shareholder meeting [52][53] Chapter 5: Board of Directors - The board of directors is responsible for the company's operations and must report to the shareholders [72] - Directors must act in the best interest of the company and its shareholders, adhering to legal and regulatory requirements [40][41] - The board must ensure that the company maintains its independence and integrity in operations [41][42]

证券日报网讯 7月30日晚间，益丰药房发布公告称，公司于2025年7月30日召开第五届董事会第十九次 会议和第五届监事会第十三次会议审议通过了《关于使用自有资金支付募投项目部分款项并以募集资金 等额置换的议案》。公司拟在"益丰数字化平台升级项目"实施期间以不超过705.00万元募集资金等额置 换自有资金先行支付的相关支出，该部分等额置换资金视同募投项目使用资金。本次募集资金等额置换 的事项无需提交股东会审议。 （编辑 任世碧） ...

Group 1 - The core point of the article is that Yifeng Pharmacy announced an extension for the completion date of its fundraising investment project, specifically the "Yifeng Digital Platform Upgrade Project," to December 31, 2025 [1] Group 2 - The fifth board meeting and the thirteenth supervisory board meeting were held on July 30, 2025, to review and approve the proposal for the extension of the fundraising investment project [1]

（文章来源：证券日报） 证券日报网讯 7月30日晚间，益丰药房发布公告称，公司第五届董事会第十九次会议审议通过了《关于 取消监事会并修订的议案》等多项议案。 ...

Group 1 - The company held its fourth supervisory board meeting, with all three supervisors present, confirming compliance with relevant laws and regulations [1][2] - The supervisory board approved the proposal to temporarily use part of the idle raised funds to supplement working capital, which is expected to enhance fund utilization efficiency and reduce financial costs [1][2] - The decision to use idle funds does not affect the normal implementation of investment projects and is in the interest of the company and all shareholders [1]